PROSPECT MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: D82087 | NORWICH, NR3 2HW
Showing results 51-100 of 484
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ibuprofen | 611 | 66.6K | £3.0K | +20.1% ▲ |
| Doxazosin mesilate | 599 | 29.8K | £824 | -43.9% ▼ |
| Lamotrigine | 593 | 28.1K | £1.4K | +0.4% vs avg |
| Prednisolone | 592 | 30.6K | £734 | -25.9% ▼ |
| Allopurinol | 561 | 26.8K | £598 | -45.6% ▼ |
| Duloxetine hydrochloride | 558 | 19.3K | £1.5K | -12.2% ▼ |
| Perindopril erbumine | 545 | 15.4K | £1.5K | +2.7% ▲ |
| Alendronic acid | 544 | 2,304 | £525 | -27.5% ▼ |
| Edoxaban | 539 | 16.9K | £28.1K | -23.1% ▼ |
| Doxycycline hyclate | 537 | 5,185 | £524 | +4.8% ▲ |
| Apixaban | 518 | 27.6K | £2.4K | -60.9% ▼ |
| Amoxicillin | 514 | 27.7K | £677 | -44.9% ▼ |
| Methylphenidate hydrochloride | 511 | 14.8K | £8.4K | +97.9% ▲ |
| Ezetimibe | 495 | 16.3K | £2.8K | -30.4% ▼ |
| Alginic acid compound preparations | 474 | 264.8K | £3.5K | -19.1% ▼ |
| Sildenafil (Erectile Dysfunction) | 473 | 4,204 | £570 | -6.2% ▼ |
| Olanzapine | 457 | 9,583 | £1.4K | +23.4% ▲ |
| Isosorbide mononitrate | 449 | 10.6K | £2.0K | -32.1% ▼ |
| Spironolactone | 433 | 11.6K | £1.7K | -19.7% ▼ |
| Other emollient preparations | 428 | 254.6K | £3.2K | -28.7% ▼ |
| 425 | 444 | £19.5K | +36.8% ▲ | |
| Rosuvastatin calcium | 423 | 13.7K | £511 | -52.9% ▼ |
| Budesonide | 423 | 870 | £15.1K | -22.0% ▼ |
| Aripiprazole | 416 | 8,916 | £1.3K | +63.5% ▲ |
| Sodium valproate | 412 | 34.7K | £4.7K | +29.5% ▲ |
| Rivaroxaban | 411 | 11.0K | £8.2K | -32.8% ▼ |
| Cetirizine hydrochloride | 406 | 31.3K | £1.7K | -18.7% ▼ |
| Codeine phosphate | 406 | 31.0K | £1.1K | -43.5% ▼ |
| Indapamide | 400 | 12.5K | £341 | -53.6% ▼ |
| Fluticasone/umeclidinium/vilanterol | 390 | 399 | £16.9K | +66.4% ▲ |
| 390 | 4,732 | £2.6K | -41.3% ▼ | |
| Desogestrel | 388 | 82.0K | £2.4K | -2.1% ▼ |
| Famotidine | 381 | 12.0K | £6.5K | -21.9% ▼ |
| Carbocisteine | 375 | 69.7K | £1.6K | -29.8% ▼ |
| Mometasone furoate | 372 | 387 | £3.0K | -7.3% ▼ |
| Insulin aspart | 367 | 2,314 | £16.2K | -3.6% ▼ |
| Atenolol | 366 | 12.8K | £279 | -39.3% ▼ |
| Esomeprazole | 363 | 10.3K | £615 | -10.3% ▼ |
| Losartan potassium | 359 | 13.2K | £376 | -79.7% ▼ |
| 356 | 1,575 | £602 | +61.6% ▲ | |
| Dihydrocodeine tartrate | 351 | 22.4K | £1.6K | +79.7% ▲ |
| 351 | 731 | £24.1K | -35.6% ▼ | |
| 349 | 40.8K | £1.1K | +26.2% ▲ | |
| Hyoscine butylbromide | 345 | 31.6K | £2.3K | +48.0% ▲ |
| Fluticasone propionate (Inhalation) | 341 | 395 | £8.8K | -11.9% ▼ |
| Buprenorphine | 341 | 5,468 | £5.3K | -6.9% ▼ |
| Alogliptin | 330 | 11.0K | £9.9K | +30.1% ▲ |
| 326 | 62.6K | £1.4K | -31.3% ▼ | |
| Clonazepam | 315 | 12.4K | £2.2K | +102.2% ▲ |
| Senna | 314 | 16.2K | £340 | -47.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.